Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Cash from Operations (2020 - 2025)

Bio Essence has reported Cash from Operations over the past 6 years, most recently at 1241052.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 182.69% year-over-year to 1241052.0; the TTM value through Dec 2025 reached 1569753.0, up 145.34%, while the annual FY2025 figure was 1569753.0, 145.34% up from the prior year.
  • Cash from Operations for Q4 2025 was 1241052.0 at Bio Essence, up from 186973.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 1241052.0 in Q4 2025 and troughed at 824074.0 in Q4 2023.
  • A 5-year average of 40673.1 and a median of 82114.0 in 2022 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: tumbled 537.42% in 2023 and later skyrocketed 998.65% in 2025.
  • Year by year, Cash from Operations stood at 142565.0 in 2021, then increased by 9.32% to 129283.0 in 2022, then tumbled by 537.42% to 824074.0 in 2023, then skyrocketed by 153.27% to 439018.0 in 2024, then skyrocketed by 182.69% to 1241052.0 in 2025.
  • Business Quant data shows Cash from Operations for BIOE at 1241052.0 in Q4 2025, 186973.0 in Q3 2025, and 167797.0 in Q2 2025.